Ovarian cancer is the most lethal of all gynecological malignancies. This is in part because of the symptomology of the disease until it is at a late stage. Because of the five-year survival rate is only 45% while the actual cause of epithelial cancer of the ovary or fallopian tube is not known, studies have found about 15% are shown to be connected with the inherited genetic factors such as BRCA 1&2 mutations. The standard line of defense is surgery and treatment with platinum-based chemotherapy. Unfortunately, recurrence is high with the recurring disease resistant to further chemotherapy. Recently olaparib has shown some promise in treating BRCA 1&2 mutations that have led to ovarian cancer. It is thought this occurs along the DNA repair pathways that make the cancer cells sensitive to olaparib. The validity of the study's data was confirmed by repeated tests across different fields (Fleury et al. 2017).
Ads by Google
In high-income countries, cancer remains the commonest cause of disease-related death in adolescent and young adults despite survival improvements. With more than one million new diagnoses of cancer in adolescents and young adults annually worldwide, and their number of life-years affected by cancer being greatest of all ages, the global burden of cancer in adolescents and young adults exceeds all other ages. In low- and middle-income countries, where the great majority of the worlds adolescents and young adults reside the needs of those with cancer have been identified and demand attention. Unique to this age group, the psychosocial challenges they face are the utmost across life's spectrum (Brunet et al, 2018)
Ovarian cancer begins in the female organs that produce eggs (ovaries), and often goes undetected until it has spread within the pelvis and stomach. The American cancer Society estimates that about 22,440 women will receive a new diagnosis of ovarian cancer in 2017. Usually women are advised to undergo surgery, chemotherapy, radiotherapy and other treatments that may incur lasting side effects and do not necessarily translate into surviving cancer. Though these mainstream cancer treatments are prioritized, there are other scientifically tested natural approaches to treat ovarian cancer.
Epidemiological studies have suggested that dietary factors may be the cause for a higher risk of developing ovarian cancer. However, the risk of developing ovarian cancer can be reduced, through dietary changes, according to multiple studies.
Researchers at Kumamoto University in Japan say they have isolated a natural compound isolated from onions called onionin A (ONA) which has several properties that help fight ovarian cancer.
Diet and healthy weight are both factors that you can control to reduce your risk for ovarian cancer. A new study focuses on calcium and vitamin D intake, and their effect on your overall risk.
A commonly used class of heart medications known as beta-blockers is shown in a first study to improve ovarian cancer survival. The medications block tumor growth and spread by interfering with the stress pathway involved with cancer metastasis.